Literature DB >> 7461029

Plasma membrane cholesterol regulates human lymphocyte cytotoxic function.

M P Dabrowski, W E Peel, A E Thomson.   

Abstract

Cell cholesterol is believed to be confined mainly to the plasma membrane. Treatment here of human peripheral blood lymphocytes with cholesterol-free and cholesterol-containing liposomes to effect, respectively, decreases or increases in cholesterol content measureable by chemical analysis, markedly altered effector functions of the cells. Depletion of cholesterol evoked inhibition of spontaneous and phytohemagglutinin-dependent lymphocyte cytotoxicity against allogeneic target cells. Opposite effects resulted from cholesterol enrichment, with PHA-dependent and antibody-dependent cytotoxicities increasing significantly. Treatment, instead, with the known inhibitor of cholesterol biosynthesis, 25-hydroxycholesterol, had suppressive effects like those resulting from lowering the cholesterol level physically by liposome treatment. Our data suggest that the plasma membrane cholesterol content of different categories of lymphocytes in man is both essential and regulatory for their cytotoxic function.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7461029     DOI: 10.1002/eji.1830101105

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Interfacial free energies and the control of the positioning and aggregation of membrane protein.

Authors:  D F Gerson
Journal:  Biophys J       Date:  1982-01       Impact factor: 4.033

2.  Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.

Authors:  Subha Banerjee; June Ghosh; Subha Sen; Rajan Guha; Ranjan Dhar; Moumita Ghosh; Sanchita Datta; Bikramjit Raychaudhury; Kshudiram Naskar; Arun Kumar Haldar; C S Lal; K Pandey; V N R Das; Pradeep Das; Syamal Roy
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

3.  Pleiotropic effects of positively charged liposomes on immune functions.

Authors:  H M Thérien; J Gruda
Journal:  In Vitro Cell Dev Biol       Date:  1990-05

4.  In vitro effects of human lipoproteins on the immune system in healthy donors: inhibition of plaque forming cell generation and decreased frequency of NK cells.

Authors:  S Antonaci; E Jirillo; M T Ventura; A Capurso; A R Garofalo; L Bonomo
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

5.  Subcapsular thymic lymphoblasts expose receptors for soy bean lectin.

Authors:  A Raedler; E Raedler; W M Becker; R Arndt; H G Thiele
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

6.  Changes in cholesterol level correlate with the course of pulmonary nontuberculous mycobacterial disease.

Authors:  Ji Young Hong; Go Eun Yang; Yousang Ko; Yong Bum Park; Yun Su Sim; Sung Hoon Park; Chang Youl Lee; Ki-Suck Jung; Myung Goo Lee
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

7.  Cholesterol synthesis in polyclonally activated cytotoxic lymphocytes and its requirement for differentiation and proliferation.

Authors:  H J Heiniger; J D Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

8.  Characterization of immunogenic properties of haptenated liposomal model membranes in mice. VII. Synergistic responses to haptenated liposomes and haptenated thymus-dependent antigens in CBA/N mice.

Authors:  H Snippe; A J Van Houte; A Janssen; E F Lizzio; J M Willers; B Merchant
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

9.  Cholesterol lowering drug may influence cellular immune response by altering MHC II function.

Authors:  Koushik Roy; Moumita Ghosh; Tuhin Kumar Pal; Saikat Chakrabarti; Syamal Roy
Journal:  J Lipid Res       Date:  2013-09-13       Impact factor: 5.922

10.  The CYP7A1 gene rs3808607 variant is associated with susceptibility of tuberculosis in Moroccan population.

Authors:  Mounia Qrafli; Youssef Amar; Jamaleddine Bourkadi; Jouda Ben Amor; Ghali Iraki; Youssef Bakri; Saaîd Amzazi; Ouafae Lahlou; Fouad Seghrouchni; Rajae El Aouad; Khalid Sadki
Journal:  Pan Afr Med J       Date:  2014-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.